nutch_noindex
CANCEL
COVID-2019 Alert

Information about the 2019 Novel Coronavirus. Read the latest >

Información sobre el coronavirus 2019 (COVID-19). Aprenda más >

/nutch_noindex

Nicolas Cuttriss, MD

  • Nicolas Leigh Cuttriss
  • “One of the most important things I can do as a physician is to empower my patients to live life to their fullest potential.”

I first became interested in pediatric endocrinology after meeting a child living with type 1 diabetes in Ecuador. That meeting inspired my life’s work. I realized that caring for kids with chronic conditions isn’t just about providing medical care. It’s also about making sure they and their families have access to education, support and the best tools for managing their condition. To that extent, I co-founded AYUDA, a nonprofit organization that supports diabetes empowerment programs throughout the world.

As a physician, I am dedicated to providing the same level of thorough care to my patients as I would expect for my own children. I believe one of the most important things I can do as a physician is to empower my patients to live life to their fullest potential. Learning about my patients’ achievements gives me the greatest pleasure.

In my work at Stanford, I’m developing programs that will help improve access to education and support for people with diabetes and their families. This is my passion, and I work each day to make sure we are constantly improving the lives of children with this condition.

Specialties

Endocrinology

Work and Education

Professional Education

George Washington University School of Medicine and Health Sciences, Washington, DC, 05/31/2007

Residency

Harbor UCLA Medical Center, Torrance, CA, United States of America, 06/30/2011

Fellowship

University of Miami Miller School of Medicine/Jackson Memorial Hospital, Miami, FL, 06/30/2014

Board Certifications

Pediatric Endocrinology, American Board of Pediatrics

Pediatrics, American Board of Pediatrics

Services

Endocrinology

Conditions Treated

Autoimmune Thyroid Disorders

Diabetes

Diabetes (Type 1 and Type 2)

Monogenic Diabetes

Short Stature and Growth Disorders

All Publications

The Neighborhood Deprivation Index and Provider Geocoding Identify Critical Catchment Areas for Diabetes Outreach. The Journal of clinical endocrinology and metabolism Walker, A. F., Hu, H., Cuttriss, N., Anez-Zabala, C., Yabut, K., Haller, M. J., Maahs, D. M. 2020

Abstract

PURPOSE: In designing a Project ECHO Type 1 Diabetes (T1D) program in Florida and California, the Neighborhood Deprivation Index (NDI) was used in conjunction with geocoding of primary care providers (PCPs) and endocrinologists in each state to concurrently identify areas with low endocrinology provider density and high health risk/poverty areas. The NDI measures many aspects of poverty proven to be critical indicators of health outcomes.METHODS: The data from the 2013-2017 American Community Survey (ACS) 5-year estimates were used to create NDI maps for California and Florida. In addition, geocoding and 30-minute drive-time buffers were performed using publicly available provider directories for PCPs and endocrinologists in both states by Google Geocoding API and TravelTime Search Application Programming Interface (API).RESULTS: Based on these findings, we defined high need catchment areas as areas with: 1) more than a 30-minute drive to the nearest endocrinologist, but within a 30-minute drive to the nearest PCP; 2) an NDI in the highest quartile; and 3) a population above the median (5,199 for census tracts, and 1,394 for census block groups). Out of the 12,181 census tracts and 34,490 census block groups in California and Florida, we identified 57 tracts and 215 block groups meeting these criteria as high need catchment area.CONCLUSION: Geospatial analysis provides an important initial methodologic step to effectively focus outreach efforts in diabetes program development. The integration of the NDI with geocoded provider directories enables more cost-effective and targeted interventions to reach the most vulnerable populations living with T1D.

View details for DOI 10.1210/clinem/dgaa462

View details for PubMedID 32676640

Tele-rounds and Case-Based Training: Project ECHO Telementoring Model Applied to Complex Diabetes Care. Pediatric clinics of North America Cuttriss, N., Bouchonville, M. F., Maahs, D. M., Walker, A. F. 2020; 67 (4): 75972

Abstract

Lack of access to subspecialty care and persistent suboptimal outcomes for insulin-requiring patients with diabetes mandates development of innovative health care delivery models. The workforce shortage of endocrinologists in the United States results in primary care providers taking on the role of diabetes specialists despite lack of confidence and knowledge in complex diabetes management. The telementoring model Project ECHO amplifies and democratizes specialty knowledge to reduce disparities in care and improve health outcomes. Project ECHO can be applied to type 1 diabetes and other complex medical conditions to address health disparities and urgent needs of complex patients throughout the lifespan.

View details for DOI 10.1016/j.pcl.2020.04.017

View details for PubMedID 32650871

Primary Care Providers in California and Florida Report Low Confidence in Providing Type 1 Diabetes Care. Clinical diabetes : a publication of the American Diabetes Association Lal, R. A., Cuttriss, N., Haller, M. J., Yabut, K., Anez-Zabala, C., Hood, K. K., Sheehan, E., Basina, M., Bernier, A., Baer, L. G., Filipp, S. L., Wang, C. J., Town, M. A., Gurka, M. J., Maahs, D. M., Walker, A. F. 2020; 38 (2): 15965

Abstract

People with type 1 diabetes may receive a significant portion of their care from primary care providers (PCPs). To understand the involvement of PCPs in delivering type 1 diabetes care, we performed surveys in California and Florida, two of the most populous and diverse states in the United States. PCPs fill insulin prescriptions but report low confidence in providing type 1 diabetes care and difficulty accessing specialty referrals to endocrinologists.

View details for DOI 10.2337/cd19-0060

View details for PubMedID 32327888

View details for PubMedCentralID PMC7164993